Benralizumab (INN) is a monoclonal antibody which is being developed by MedImmune for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125).
Download resources about recombinant antibody development and antibody engineering to boost your research.
|MOB-2473z||Mouse Anti-IL5RA Recombinant Antibody (clone 33H12)||WB, FC||Mouse IgG1|
|HPAB-1545WJ||Human Anti-IL5RA Recombinant Antibody (clone KM1399)||ELISA, WB||Human IgG1, κ|
|TAB-222||Anti-Human IL5RA Recombinant Antibody (Benralizumab)||WB, FC, IP, ELISA, Neut, FuncS, IF||IgG1 - kappa|
|MOR-1813||Rabbit Anti-IL5RA Recombinant Antibody (clone DS1813AB)||WB||Rabbit IgG|
|AFC-TAB-222||Afuco™ Anti-IL5RA ADCC Recombinant Antibody (Benralizumab), ADCC Enhanced||FC, IP, ELISA, Neut, FuncS||ADCC enhanced antibody|
|HPAB-1545WJ-F(E)||Human Anti-IL5RA Recombinant Antibody; Fab Fragment (clone KM1399)||ELISA, WB||Human Fab|
|HPAB-1545WJ-S(P)||Human Anti-IL5RA Recombinant Antibody; scFv Fragment (clone KM1399)||ELISA, WB||Human scFv|
Submit a review or a question
There are currently no Customer reviews or questions for Gly-006CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.